XML 34 R23.htm IDEA: XBRL DOCUMENT v3.21.1
Stockholders' Equity (Tables)
3 Months Ended
Mar. 31, 2021
Schedule of basic and diluted per share results

 

 

For the Three Months Ended

For the Month Ended

 

 

Mar. 31, 2021

    

Mar. 31, 2020

Dec. 31, 2020

Dec. 31, 2019

Net (loss) income

$

(768)

$

(286)

$

1,981

$

(255)

Weighted average shares outstanding for computation of basic per share results

 

6,236,000

 

5,088,000

 

5,663,000

 

5,075,000

Incremental shares from assumed exercise of stock options (a)

 

 

 

181,000

 

Adjusted weighted average shares for computation of diluted per share results

 

6,236,000

 

5,088,000

 

5,844,000

 

5,075,000

(a)Incremental shares from the assumed exercise of INDUS stock options are not included in periods where the inclusion of such shares would be anti-dilutive. The incremental shares from the assumed exercise of stock options for the 2021 first quarter, 2020 first quarter and month ended December 31, 2019 would have been 95,000, 52,000, and 51,000, respectively. For the 2021 first quarter, there was a Warrant for the purchase of 515,747 shares of Common Stock, as adjusted for the stock dividend in the 2021 first quarter, that was anti-dilutive.
Schedule of options granted by INDUS under the Stock Option Plan to non-employee directors

For the Three Months Ended

Mar. 31, 2020

    

    

Fair Value per

Number of

Option at

Shares

Grant Date

Non-employee directors

102,906

$

12.29 - 14.17

Schedule of option holders

Number of option holders at March 31, 2021

      

28

Schedule of unrecognized compensation expense related to nonvested stock options

Balance of Fiscal 2021

    

$

343

Fiscal 2022

$

374

Fiscal 2023

$

231

Fiscal 2024

$

111

Fiscal 2025

$

15

Summary of the activity under the INDUS Stock Option Plan

For the Three Months Ended

Mar. 31, 2021

Mar. 31, 2020

Number of

Weighted Avg.

Number of

Weighted Avg.

Shares

Exercise Price

Shares

Exercise Price

Outstanding at beginning of period

 

246,150

$

36.06

 

189,822

$

28.23

Adjustment for stock dividend

5,413

$

34.29

$

Granted

 

$

 

102,906

$

46.32

Exercised

 

(233)

$

26.31

 

$

Outstanding at end of period

 

251,330

$

35.28

 

292,728

$

34.59

Schedule of options by range of exercise prices

 

    

 

    

 

 

    

Weighted Avg.

    

 

 

 

 

 

 

 

 

 

Remaining

 

 

 

Range of Exercise Prices for

 

Outstanding at

 

Weighted Avg.

 

Contractual Life

 

Total Intrinsic

Outstanding Options

 

March 31, 2021

 

Exercise Price

 

(in years)

 

Value

$23.00 - $28.00

 

111,313

$

26.25

 

4.9

 

$

3,775

$28.00 - $32.00

 

14,073

$

29.84

 

4.3

 

427

$32.00 - $47.00

 

125,944

$

43.88

 

8.7

 

2,050

 

251,330

$

35.28

 

6.8

$

6,252

Vested options

101,941

$

27.88

 

5.0

 

$

3,291

Schedule of compensation expense and related tax benefits for stock options

 

For the Three Months Ended

For the Month Ended

 

    

Mar. 31, 2021

    

Mar. 31, 2020

Dec. 31, 2020

Dec. 31, 2019

Compensation expense

$

214

$

122

$

41

$

19

Related tax benefit

$

$

28

$

$

4

Schedule of accumulated other comprehensive income (loss)

For the Three Months Ended 

For the Month Ended

Mar. 31, 2021

Mar. 31, 2020

Dec. 31, 2020

Dec. 31, 2019

Balance at beginning of period

 

$

(7,855)

 

$

(2,540)

$

(8,051)

$

(3,141)

Other comprehensive gain (loss) before reclassifications

 

2,991

 

(4,964)

 

14

 

568

Amounts reclassified

 

488

 

103

 

182

 

33

Net activity for other comprehensive gain (loss)

 

3,479

 

(4,861)

 

196

 

601

Balance at end of period

 

$

(4,376)

 

$

(7,401)

$

(7,855)

$

(2,540)

Schedule of components of accumulated other comprehensive income (loss)

 

 

For the Three Months Ended

 

Mar. 31, 2021

 

Mar. 31, 2020

 

 

 

 

 

Tax

 

 

 

 

 

 

 

Tax

 

 

 

 

 

 

 

 

(Expense)

 

Net-of

 

 

 

 

(Expense)

 

Net-of

 

    

Pre-Tax

    

Benefit

    

Tax

    

Pre-Tax

    

Benefit

    

Tax

Reclassification included in net loss:

Loss on cash flow hedges (interest expense)

$

488

 

$

 

$

488

 

$

135

 

$

(32)

 

$

103

Change in other comprehensive income (loss):

Increase (decrease) in fair value of cash flow hedges

 

2,991

 

 

2,991

 

(6,602)

 

1,638

 

(4,964)

Other comprehensive income (loss)

$

3,479

 

$

 

$

3,479

 

$

(6,467)

 

$

1,606

 

$

(4,861)

 

 

For the Month Ended

 

Dec. 31, 2020

 

Dec. 31, 2019

 

 

 

 

 

Tax

 

 

 

 

 

 

 

Tax

 

 

 

 

 

 

 

 

(Expense)

 

Net-of

 

 

 

 

(Expense)

 

Net-of

 

    

Pre-Tax

    

Benefit

    

Tax

    

Pre-Tax

    

Benefit

    

Tax

Reclassification included in net income (loss):

Loss on cash flow hedges (interest expense)

$

182

 

$

 

$

182

 

$

43

 

$

(10)

 

$

33

Change in other comprehensive income (loss):

Increase (decrease) in fair value of cash flow hedges

 

14

 

 

14

 

739

 

(171)

 

568

Other comprehensive income (loss)

$

196

 

$

 

$

196

 

$

782

 

$

(181)

 

$

601

Restricted Stock Units (RSUs) [Member]  
Schedule of unrecognized compensation expense related to nonvested stock options

Balance of Fiscal 2021

    

$

403

Fiscal 2022

$

379

Fiscal 2023

$

285

Fiscal 2024

$

23